Eli Lilly & Co.
$1,152.93
Market Cap
$1.03T
Shares Outstanding
891.4M
Primary Exchange
XNYS
Currency
USD
Type
CS
IPO Date
Jul 9, 1970
Round Lot
40
Locale
US
Day Open
$1150.00
Day High
$1157.60
Day Low
$1140.27
Volume
4.55M
VWAP
$1151.69
Prev Close
$1152.44
Transactions
--
Acc. Volume
--
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Eli Lilly & Co. (LLY) closed the 2026-09-18 session at $1152.93, up 0.04% versus the previous close (+0.49). The stock opened at $1150.00 and traded between $1140.27 and $1157.60 during that session. Session trading volume was 4.5M shares. The volume-weighted average price (VWAP) is $1151.69.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Eli Lilly & Co. has a market capitalization of $1.03 trillion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. LLY is listed on the XNYS exchange. The company employs approximately 50,000 people. Eli Lilly & Co. is headquartered in INDIANAPOLIS, IN. The recorded listing date is 1970-07-09.
On this page you can find market LLY stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.